Guided Therapeutics, Inc. (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it is scheduled to report financial results for its first quarter ended March 31, 2014 on...
Guided Therapeutics, Inc. (OTCQB: GTHP) today announced that it has agreed to sell, in a private placement to Hanover Holdings I, LLC, an affiliate of Magna Group (“Magna”), up to $3,000,000 in aggregate principal amount of 6% Senior Convertible Notes due 18 months...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that the company has been given a face-to-face meeting date of May 8, 2014, by the U.S. Food and Drug Administration (FDA), to discuss the company’s response to the September 6, 2013 not-approvable...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP), today announced that the LuViva® Advanced Cervical Scan, its non-invasive device used to detect cervical disease instantly at the point of care, has been selected as a finalist in the Hospital Devices and...
Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that the company has submitted a letter requesting a face-to-face meeting with the U.S. Food and Drug Administration (FDA) in the next 60 to 90 days. This letter is in response to the September 6,...
